Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)	6 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
OPERATING ACTIVITIES:
Net loss	$ (811,146)	$ (1,188,272)
Loss from discontinued operations	0	(131,823)
Net loss from continuing operations	(811,146)	(1,056,449)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	40,492	35,085
Stock-based compensation	13,000	39,000
Amortization of debt discount and beneficial conversion feature	30,548	104,499
Changes in operating assets and liabilities:
Prepaid expenses and other current assets	(126,794)	36,010
Accounts payable	(102,254)	(30,120)
Accrued expenses	7,444	27,414
Accrued interest	41,146	55,857
Net cash used in operating activities of continuing operations	(907,564)	(788,704)
Net cash provided by operating activities of discontinued operations	0	16,243
Net cash used in operating activities	(907,564)	(772,461)
INVESTING ACTIVITIES:
Proceeds from sale of Nevada subsidiaries	0	200,000
Acquisition of intangible assets	(30,320)	(100,000)
Net cash provided by/(used in) investing activities of continuing operations	(30,320)	100,000
Net cash provided by investing activities of discontinued operations	0	1,502
Net cash provided by/(used in) investing activities	(30,320)	101,502
FINANCING ACTIVITIES:
Gross proceeds from warrant exercises	0	62,660
Proceeds from issuing convertible note	0	50,000
Gross proceeds from issuing common stock	1,595,000	0
Brokerage fees for common stock sales	(207,350)	0
Principal payment on notes and convertible notes payable	(25,905)	0
Net cash provided by financing activities of continuing operations	1,361,745	112,660
Net cash used in financing activities of discontinued operations	0	(67,931)
Net cash provided by financing activities	1,361,745	44,729
Net change in cash and cash equivalents	423,861	(626,230)
CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD	233,893	1,145,633
CASH AND CASH EQUIVALENTS AT END OF PERIOD	657,754	519,403
Less: cash and cash equivalents classified as discontinued operations	0	(124,078)
CASH AND CASH EQUIVALENTS AT END OF PERIOD FROM CONTINUING OPERATIONS	657,754	395,325
Cash paid for interest	0	0
Cash paid for income tax	0	0
Non-cash investing and financing transactions:
Compensation warrants issued to brokers in private placement	145,150	0
Depreciation capitalized in inventory (discontinued operations)	0	213,425
Accrued patent drafting and filing costs capitalized in intangible assets	27,069	189,880
Accrued brokerage fees for convertible notes and warrant exercises	0	12,776
Stock options issued as compensation for drafting and filing patent applications	0	28,800
Induced dividend from warrant exercises	$ 0	$ 163,017